Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Comstock Holding Companies (CHCI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Comstock Holding Companies (CHCI) over the last 17 years, with Q3 2025 value amounting to $26.2 million.

  • Comstock Holding Companies' Cash & Equivalents rose 2432.19% to $26.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.2 million, marking a year-over-year increase of 2432.19%. This contributed to the annual value of $28.8 million for FY2024, which is 5308.18% up from last year.
  • Comstock Holding Companies' Cash & Equivalents amounted to $26.2 million in Q3 2025, which was up 2432.19% from $30.5 million recorded in Q2 2025.
  • In the past 5 years, Comstock Holding Companies' Cash & Equivalents registered a high of $30.5 million during Q2 2025, and its lowest value of $5.4 million during Q3 2022.
  • For the 5-year period, Comstock Holding Companies' Cash & Equivalents averaged around $15.5 million, with its median value being $11.7 million (2022).
  • As far as peak fluctuations go, Comstock Holding Companies' Cash & Equivalents surged by 22468.98% in 2021, and later crashed by 4083.28% in 2022.
  • Comstock Holding Companies' Cash & Equivalents (Quarter) stood at $15.8 million in 2021, then dropped by 25.92% to $11.7 million in 2022, then surged by 60.28% to $18.8 million in 2023, then surged by 53.08% to $28.8 million in 2024, then decreased by 9.01% to $26.2 million in 2025.
  • Its Cash & Equivalents stands at $26.2 million for Q3 2025, versus $30.5 million for Q2 2025 and $28.3 million for Q1 2025.